Literature DB >> 11153692

Patient positioning in static beams for boron neutron capture therapy of malignant glioma.

L Wielopolski1, J Capala, N E Pendzick, A D Chanana.   

Abstract

PURPOSE: To develop a procedure for the optimum patient positioning and immobilization during boron neutron capture therapy (BNCT) of glioblastoma multiforme (GBM) at the Brookhaven medical research reactor (BMRR).
METHODS: A replica of the treatment room in the BMRR was constructed to simulate patient position. A unique feature is a transparent opening in wall to simulate the location of the beam port and to provide a beam-eye view of the head. A portable stereotactic frame was built to facilitate head markings. These marking provide critical reference points for determining the entry point of the central beam axis and patient positioning coordinates calculated relative to these points. RESULT: This patient positioning and immobilization system has proven to be satisfactory in minimizing the variations from the planned BNCT radiation doses.
CONCLUSION: The approach described herein has been satisfactory in treating patients with GBM. These patients are minimally sedated during BNCT lasting from 38 to 73 minutes.

Entities:  

Mesh:

Year:  2000        PMID: 11153692

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  2 in total

1.  Dosimetric effect of set-up error in accelerator-based boron neutron capture therapy for head and neck cancer.

Authors:  Shinya Komori; Katsumi Hirose; Mariko Sato; Akihiko Takeuchi; Ryohei Kato; Tomoaki Motoyanagi; Takaomi Harada; Yuhei Yamazaki; Mayumi Harada; Yuki Narita; Takahiro Kato; Yoshihiro Takai
Journal:  J Radiat Res       Date:  2022-07-19       Impact factor: 2.438

2.  The Dosimetric Impact of Shifts in Patient Positioning during Boron Neutron Capture Therapy for Brain Tumors.

Authors:  Jia-Cheng Lee; Yi-Wei Chen; Keh-Shih Chuang; Fang-Yuh Hsu; Fong-In Chou; Shih-Ming Hsu; Sang-Hue Yen; Yuan-Hung Wu
Journal:  Biomed Res Int       Date:  2018-10-01       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.